The Google of China forecasts a gloomy quarter for the iPhone maker.
The market for multiple sclerosis drugs is worth billions of dollars every year and these are the companies that benefit most.
You might have to wait almost a decade to invest in China’s disruptive smartphone maker.
Why Amgen, Celgene, and Novavax shares are screaming to be scooped up.
Looking for inexpensive stocks to ride an aging demographic trend? These five Big Pharma stocks are trading at steep discounts.
A great way to learn about investing is to study the portfolio of the best investor in the world.
Bank stocks are the worst. Here’s why.
Warren Buffett owns over $5.6 billion of Phillips 66, but it’s not the best buy in the refining sector.
Warren Buffett's investing wisdom can teach you some valuable lessons about the stock market.
Don't blink, otherwise you could miss another innovative cancer drug hitting pharmacy shelves.